Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Myriad Genetics, Inc. (MYGN)

« Back to company index

MYGN Chatter Timeline

Stock Ticker for MYGN

Most Active Tweeters for MYGN

UserTweets
@stock_titan 7
@Tickeron 6
@FlashAlert_me 6
@sbwcws 5
@MarcJacksonLA 5

Recent Tweets for MYGN

Gambiste1 @Gambiste1
RT @CSIMarket: $MYGN #StockMarket #MyriadGenetics issued first quarter of 2021 Results on https://t.co/savSNTKlN1: From the preceding quart…
May 7th 2021, 6:05am
CSIMarket @CSIMarket
$MYGN #StockMarket #MyriadGenetics issued first quarter of 2021 Results on https://t.co/savSNTKlN1: From the preced… https://t.co/GkjloN5gw8
May 7th 2021, 5:05am
MarcJacksonLA @MarcJacksonLA
$MYGN BTIG Maintains Buy Rating On Myriad Genetics, $37 PT https://t.co/CJlfiMbk9s
May 6th 2021, 2:05pm
shortablestocks @shortablestocks
$MYGN is short sale restricted for 2021-05-06. https://t.co/1184JCs8Xf
May 6th 2021, 1:05pm
insiderbuyings @insiderbuyings
$MYGN new insider selling: 19360 shares. https://t.co/qVAU9HFooF
May 6th 2021, 7:05am
Tickeron @Tickeron
$MYGN's 10-day Moving Average moved above its 50-day Moving Average on May 3, 2021. View odds for this and other in… https://t.co/zGek8OPyYq
May 6th 2021, 5:05am
InsiderAlerts4U @InsiderAlerts4U
$MYGN: New Insider Filing on MYRIAD GENETICS INC's Chief Scientific Officer JERRY S LANCHBURY: https://t.co/FCv3zAyAMm
May 6th 2021, 3:05am
EZMoney_41 @EZMoney_41
$MYGN Still going down https://t.co/FAZMjDLEiB
May 6th 2021, 2:05am
StockTexts @StockTexts
$MYGN Myriad Genetics, Inc. SEC Filing: Form 4 https://t.co/LNbMOpZt0x
May 6th 2021, 12:05am
fintel_io @fintel_io
Insider Jerry S Lanchbury reports selling 19,360 shares of $MYGN for a total cost of $618,948.88 https://t.co/kWMYSy7Cdq
May 5th 2021, 11:05pm
FlashAlert_me @FlashAlert_me
$MYGN [15s. delayed] filed SEC form 4: Chief Scientific Officer LANCHBURY JERRY S: Disposed 19,360 of Common Stock… https://t.co/xa1gs4MA8m
May 5th 2021, 11:05pm
kevinjaybe @kevinjaybe
$MYGN Myriad Genetics Ceo Paul J. Diaz To Present At Bank Of America Securities 2021 Virtual Health Care Conference https://t.co/zuLR1eeAQo
May 5th 2021, 8:05pm
stock_titan @stock_titan
$MYGN Myriad Genetics CEO Paul J. Diaz to Present at Bank of America Securities 2021 Virtual Health Care Conference https://t.co/8ANPX4WlJ1
May 5th 2021, 8:05pm
TerraPharma1 @TerraPharma1
$MYGN down 5% after earnings. "Transformation" plan not too convincing??
May 5th 2021, 2:05pm
StockTexts @StockTexts
$MYGN Myriad Genetics, Inc. SEC Filing: Form 10-Q https://t.co/NSG0qGc4X2
May 5th 2021, 11:05am
Allstocknews @Allstocknews
$MYGN New Form 10-Q for Myriad Genetics, Inc. From our Stock News Alerts App
May 5th 2021, 11:05am
fintel_io @fintel_io
$MYGN / Myriad Genetics files form 10-Q https://t.co/10uBQNeH4w
May 5th 2021, 11:05am
EdgarInsider @EdgarInsider
A Form 10-Q [Quarterly Report] filing has been made with the SEC: $MYGN MYRIAD GENETICS INC https://t.co/M8z5SWkifT
May 5th 2021, 11:05am
FlashAlert_me @FlashAlert_me
$MYGN [15s. delayed] filed form 10-Q on May 05, 07:05:47 https://t.co/XJoT78JMMf
May 5th 2021, 11:05am
Tickeron @Tickeron
$MYGN's 10-day Moving Average crossed above its 50-day Moving Average on May 3, 2021. View odds for this and other… https://t.co/oHYiAD0duG
May 4th 2021, 11:05pm
42Stocks @42Stocks
https://t.co/dtAK7h3mik 2021-MAY-04 7:15pm $MYGN #MyriadGenetics up 4.01% = $92.9 million gain. (May 04) Myriad G… https://t.co/cXvWNpGlaa
May 4th 2021, 11:05pm
CapitolistPig @CapitolistPig
Just a reminder that $MYGN has still not disclosed all the endpoints from their failed trial https://t.co/qMR6k1ciQH
May 4th 2021, 3:05pm
stockmktgenius @stockmktgenius
$MYGN Myriad Genetics, Inc. - C Top stock up 196% from low. Close: 30.40 VolvsAvg: 1.27 Liq: $19M https://t.co/3PaXRdedRG
May 4th 2021, 6:05am
newsfilterio @newsfilterio
Myriad Genetics EPS beats by $0.09, beats on revenue $MYGN https://t.co/BoQDeTUiC6
May 4th 2021, 12:05am
Briefingcom @Briefingcom
$MYGN: Myriad Genetics beats by $0.09, beats on revs https://t.co/cyrte7gfnc
May 3rd 2021, 10:05pm
Estimize @Estimize
$MYGN beats the Estimize EPS Consensus by 6c and the Estimize Revenue Consensus by $15.73M. Reports FQ3 earnings of… https://t.co/ZbPhmetasx
May 3rd 2021, 8:05pm
Estimize @Estimize
$MYGN reports FQ3 earnings of -6c EPS and $173.10M Revs - https://t.co/s2vQUaEhnP
May 3rd 2021, 8:05pm
GeneticsShare @GeneticsShare
$MYGN Myriad Genetics Delivers 12% Sequential Revenue Growth In March 2021 Quarter - CML News https://t.co/mY6JJwy5Fn
May 3rd 2021, 8:05pm
MarcJacksonLA @MarcJacksonLA
$MYGN Myriad Genetics Delivers 12% Sequential Revenue Growth in March 2021 Quarter, Company Executes on Strategic T… https://t.co/kl52x75cd4
May 3rd 2021, 8:05pm
sbwcws @sbwcws
Myriad Genetics reports Q3 EPS 6c, consensus (14c) $MYGN
May 3rd 2021, 8:05pm
EdgarInsider @EdgarInsider
New Form 8-K [Press/News Current Report] entry filed by $MYGN MYRIAD GENETICS INC https://t.co/SLCdj6WM3t
May 3rd 2021, 8:05pm
Allstocknews @Allstocknews
$MYGN Myriad Genetics Delivers 12% Sequential Revenue Growth in March 2021 Quarter, Company Executes on Strat From our Stock News Alerts App
May 3rd 2021, 8:05pm
kevinjaybe @kevinjaybe
$MYGN Myriad Genetics Delivers 12% Sequential Revenue Growth In March 2021 Quarter, Company Executes On Strategic T… https://t.co/H3Mw7lkUxj
May 3rd 2021, 8:05pm
MarcJacksonLA @MarcJacksonLA
$MYGN $LH Myriad Genetics Signs Definitive Agreement to Sell Myriad Autoimmune’s Vectra Testing Business to Labcorp https://t.co/LX47EeiVkk
May 3rd 2021, 8:05pm
FlashAlert_me @FlashAlert_me
$MYGN [15s. delayed] filed form 8-K on May 03, 16:05:28 https://t.co/uBqe50vQcj
May 3rd 2021, 8:05pm
fintel_io @fintel_io
$MYGN / Myriad Genetics files form 8-K - Results of Operations and Financial Condition - 8-K https://t.co/10uBQNeH4w
May 3rd 2021, 8:05pm
MarcJacksonLA @MarcJacksonLA
$MYGN Myriad Genetics to Update Progress on Transformation Plan and Growth Initiatives, Share Long-Term Financial O… https://t.co/1qVouDDzwk
May 3rd 2021, 8:05pm
stock_titan @stock_titan
$MYGN Myriad Genetics Delivers 12% Sequential Revenue Growth in March 2021 Quarter, Company Executes on Strategic T… https://t.co/GQpfcXbOU1
May 3rd 2021, 8:05pm
MarcJacksonLA @MarcJacksonLA
$MYGN Myriad Genetics Targets To Be Profitable By Q4 - Quick Facts | NASDAQ https://t.co/7MLgTwaeQB
May 3rd 2021, 8:05pm
NewsQuantified @NewsQuantified
$MYGN announced that it has entered into a definitive agreement to sell select operating assets and intellectual pr… https://t.co/jrZ9pbcCDX
May 3rd 2021, 6:05pm
Gambiste1 @Gambiste1
RT @EarningsPoll: $MYGN earnings 5/3 after hours. How will the stock react?
May 3rd 2021, 5:05pm
EarningsPoll @EarningsPoll
$MYGN earnings 5/3 after hours. How will the stock react?
May 3rd 2021, 4:05pm
SmallCapsDaily @SmallCapsDaily
$MYGN Myriad Genetics Signs Definitive Agreement to Sell Myriad Autoimmunes Vectra Testing Business to Labcorp Glob… https://t.co/lhFueEKhNE
May 3rd 2021, 4:05pm
Estimize @Estimize
$MYGN reports after the close, Estimize Consensus +0.03 EPS and +2.95M Revs compared to WS - https://t.co/zJe2fw53Z6
May 3rd 2021, 3:05pm
sbwcws @sbwcws
LabCorp's Vectra deal likely not the last for this year, says William Blair $LH $MYGN
May 3rd 2021, 2:05pm
Briefingcom @Briefingcom
$MYGN: Myriad Genetics began to implement the second phase of its transformation plan this quarter, expects to be... https://t.co/l3fFr3ToEz
May 3rd 2021, 1:05pm
otcdynamics @otcdynamics
$MYGN Myriad Genetics to Update Progress on Transformation Plan and Growth Initiatives, Share Long-Term Financial O… https://t.co/BPpba2Dhey
May 3rd 2021, 11:05am
sbwcws @sbwcws
Myriad Genetics expects to be profitable by 4Q21 $MYGN
May 3rd 2021, 11:05am
stock_titan @stock_titan
$MYGN Myriad Genetics Signs Definitive Agreement to Sell Myriad Autoimmune’s Vectra Testing Business to Labcorp https://t.co/l2uh1kmHcc
May 3rd 2021, 11:05am
FlashAlert_me @FlashAlert_me
$MYGN [15s. delayed]: Issued Press Release on May 03, 07:00:00: Myriad Genetics to Update Progress on Transformatio… https://t.co/k2nYxJXESH
May 3rd 2021, 11:05am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2021. All rights reserved.